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The purpose of this paper was to characterize proteins secreted from the human nonpigmented ciliary epithelial (HNPE) cells,
which have diﬀerentiated a rat retinal ganglion cell line, RGC-5. Undiﬀerentiated RGC-5 cells have been shown to express several
markerproteinscharacteristicofretinalganglioncells.However,RGC-5cellsdonotrespondtoN-methyl-Daspartate(NMDA),or
glutamate. HNPE cells have been shown to secrete numbers of neuropeptides or neuroproteins also found in the aqueous humor,
many of which have the ability to inﬂuence the activity of neuronal cells. This paper details the proﬁle of HNPE cell-secreted
proteins by proteomic approaches. The experimental results revealed the identiﬁcation of 132 unique proteins from the HNPE
cell-conditioned SF-medium. The biological functions of a portion of these identiﬁed proteins are involved in cell diﬀerentiation.
We hypothesized that a diﬀerentiation system of HNPE cell-conditioned SF-medium with RGC-5 cells can induce a diﬀerentiated
phenotype in RGC-5 cells, with functional characteristics that more closely resemble primary cultures of rat retinal ganglion cells.
These proteins may replace harsh chemicals, which are currently used to induce cell diﬀerentiation.
1.Introduction
Primary open angle glaucoma (POAG), a leading cause of
irreversible blindness worldwide, is an optic neuropathy
characterized by the gradual and progressive loss of retinal
ganglion cells (RGCs), optic nerve degeneration, and excava-
tion of the optic disks [1–4]. The hypothesis has been that
larger RGCs were selectively lost in the early stage of glau-
coma [5]. Although the mechanisms of optic nerve damage
inglaucomahavenotbeencompletelydetermined,itappears
that the optic nerve head is a major site of damage [6].
RGCs can generate action potentials that travel along the
optic ﬁbers [7]. In general, RGCs are a mixture of more
than 20 cell subtypes. They have energy-dependent axonal2 Journal of Biomedicine and Biotechnology
transport functions—orthograde and retrograde transports
[8]. These terminal projection areas are in the lateral genic-
ulate body. RGCs can be subdivided by their morphology
and physiology, but they are usually discussed without
classiﬁcations.
The in vitro study of the physiology and pathophysiology
of RGCs has been limited to primary cultures. Previous stud-
ies have characterized a transformed rat retinal ganglion cell-
line (RGC-5), which expresses many neuronal cell markers,
including Thy-1, a cell surface glycoprotein found predom-
inantly in the retinal ganglion cells [6, 9, 10], and Brn-
3C, a POU domain transcription factor expressed exclusively
in the retinal ganglion cells [11]. RGC-5 cells also express
receptors of N-methyl-D aspartate (NMDA), GABA-B, and
neurotrophin [6]. However, unlike primary RGCs, these
cells were not sensitive to glutamate excitotoxicity in their
undiﬀerentiated state. RGC-5 cells pretreated with succinyl
concanavalin-A(sConA)weresensitiveto500μMgl utamat e
[12]. Lacking glutamate sensitivity causes the diﬃculties of
using the RGC-5 cells in experiments involving glutamate.
Ocular ciliary epithelium cells have been shown to be
involved in the synthesis and secretion of various proteins
found in aqueous humor [13]. Several proteins, including
neuropeptides and their processing enzymes, synthesized
and secreted by a human nonpigmented ciliary epithelial
(HNPE) cell-line, have been evaluated [14], and it is
suggested that these secreted proteins can act in an autocrine
or paracrine manner to aﬀect ciliary epithelial functions and
other target ocular cells, such as the trabecular meshwork
[13]. Because of the neuroendocrine properties of the
ciliary epithelium cells, the ability to confer diﬀerentiated
neuroendocrine phenotypes and the physical locations of
theseciliaryepitheliumcellsandRGCs[15],wehypothesized
that factors secreted by these HNPE cells may induce the
RGC-5 cells to diﬀerentiate, and possibly induce glutamate
and NMDA sensitivities.
Proteomic analysis, including identiﬁcation and charac-
terization, is a powerful tool for determination of biological
roles and functions of individual proteins. In the present
report, we have utilized a system involving HNPE and RGC-
5 cells, and this system may result in the morphological
and functional diﬀerentiation of RGC-5 cells. Although the
origin of RGC-5 has been still in question, the expression of
neuronal markers was validated [16]. Proteomic approaches
have been applied to establish a map of expressed proteins
for the characteristics of HNPE cells.
2.MaterialsandMethods
2.1. Cell Culture. The human non-pigmented ciliary epithe-
lium cells (HNPE) were SV-40 transformed and were
a gift from Dr. Miguel Coca-Prados (Yale University).
HNPE were maintained at 37◦C and 5% CO2 in Dul-
becco’s modiﬁed Eagle’s medium (DMEM, Gibco, Grand
Island, NY, USA) supplemented with 10% fetal bovine
serum (FBS, Hyclone Laboratories, Logan, UT), 1% peni-
cillin/streptomycin (Gibco, Grand Island, NY, USA) and
44mM NaHCO3. After three days, the cells were washed
with phosphate buﬀered saline (PBS) and the medium was
replaced by serum-free (SF) DMEM for 12h.
The HNPE cell conditioned SF-medium was ﬁltered by
0.22μm ﬁlter and diluted 25 times with autoclaved Milli-Q
grade water (Millipore Co., Inc.). For each 5kD cutoﬀ
centrifugal tube (Amicon Ultra-15, Millipore Co., Inc.), a
15mL diluted sample was loaded. Following centrifugation
at 5000×g for 20min, the sample in the ﬁlter unit was
collected. The protein concentration of the HNPE cell
conditioned SF-medium was measured by the Bio-Rad
Bradford total protein assay kit (Bio-Rad Laboratories, Inc.).
RGC-5 cells, a secondary cell culture, were transformed
rat retinal ganglion cells developed and obtained from Dr.
Agarwal (University of North Texas Health Science Center).
RGC-5 cells were maintained in low glucose DMEM in T-
150 culture ﬂasks supplemented with 44mM NaHCO3, 10%
FBS, and 1% penicillin/streptomycin (Gibco). Diﬀerentiated
RGC-5 cells were obtained by using 50% HNPE cell condi-
tioned SF-medium and 50% fresh DMEM (containing 10%
FBS). HNPE conditioned medium, which consisted of low
glucose DMEM, was incubated with human non-pigmented
ciliary epithelial cells (HNPE).
2.2. Immunocytochemistry. R G C sw e r eg r o w no ng l a s sc o v -
erslips for 1-2 days prior to experimentation. Coverslips
were rinsed with PBS three times and then were ﬁxed in
4% paraformaldehyde for 30min. These cells were washed
with PBS before being permeabilized in 0.1% Triton X-100
for 15min, washed with PBS, and blocked with 5% bovine
serum albumin for 60min. After rinsing with PBS, the
cells were incubated with a mixture of Thy-1 (monoclonal
antibodies, Chemicon, Temecula, CA, 1:200) and Brn-
3C (polyclonal antibodies, Convance Inc, Princeton, NJ,
1:1000) for 1.5h at room temperature and subsequently
incubated with a combination of secondary antibodies. After
PBS rinses, these cells were incubated for 10min in the dark
with 300nM DAPI to stain nuclear regions. Cover-slides
weremountedonglassslidesinantifademedium(FluorSave;
Calbiochem, La Jolla, CA) and allowed to dry for 20min in
the dark. Cells were visualized and images were taken using a
Zeiss LSM-410 Confocal Scanning Laser Microscope System.
Controls were performed by omitting primary antibodies.
2.3. 1D SDS-PAGE. HNPE cell-secreted proteins were sep-
arated under denaturing conditions in a 4–12% polyacry-
lamide gel. The HNPE cell conditioned SF-medium was
resuspended in the sample buﬀer (Invitrogen NuPAGE SDS
sample buﬀer), heated at 80◦C for 10min and then stored
on ice. Each well was loaded with 5μg of sample solution.
The SDS-PAGE gel was run in a Bio-Rad protean II xi cell
(Richmond CA, USA) at 200V for 1h. After completion of
electrophoresis, the protein bands in the gel were visualized
by silver staining and image acquired using an image scanner
(Amersham Biosciences, Uppsala, Sweden), which is oper-
ated by the software LabScan 5.00 (Amersham Biosciences).
2.4. Silver Staining. T h eg e l sw e r eﬁ x e di na na q u e o u s
solution having 40% ethanol and 10% acetic acid overnight,Journal of Biomedicine and Biotechnology 3
and then incubated in a buﬀer solution containing 30%
ethanol, 6.8% w/v sodium acetate, and 0.312% w/v sodium
thiosulfate for 30min. After rinsing three times for 5min
each, the gels were stained in a 0.25% w/v silver nitrate
solution containing 0.02% formaldehyde for 30min. The
development was performed for 10min in a solution con-
sisting of 2.5% sodium carbonate and 0.01% formaldehyde.
An acetic acid solution (5% v/v) was used to stop the
development, and the stained gels were then rinsed three
times for 5min each.
2.5. Protein Identiﬁcation by Nano-HPLC-ESI-MS/MS. The
protein bands were excised manually and digested using
sequencegradetrypsin(V511A,Promega,USA).Theprotein
samples were reduced, alkylated, and then digested with
trypsin using standard protocols [17, 18].
Reversephasenano-highperformanceliquidchromatog-
raphy electrospray ionization tandem mass spectrometry
(RP-nano-HPLC-ESI-MS/MS) was used to identify the
selected protein bands separated on the SDS-PAGE. The
peptides obtained from the tryptic in-gel digestion were ana-
lyzedusinganano-HPLCsystem(LCPackings,Netherlands)
coupled to an ion trap mass spectrometer (LCQ Deca XP
Plus,ThermoFinnigan,SanJose,CA,USA)equippedwithan
electrospray ionization source. A linear acetonitrile gradient
from 100% buﬀer A (5% acetonitrile/0.1% formic acid) to
60% buﬀer B (80% acetonitrile/0.1% formic acid) was used
at a ﬂow rate of approximately 200nL/min for 70min. The
separation was performed on a C18 microcapillary column
(Zorbax 300SB-C18, 3.5μm, 75μmI . D .×150mm, Agilent,
Germany). Peptides eluted from the microcapillary column
were electrosprayed into the nano-HPLC-ESI-MS/MS with
the application of a distal 1.3kV with heated capillary at
the temperature of 200◦C. Each cycle of one full scan
mass spectrum (m/z 450–2000) was followed by three data-
dependenttandemmassspectrawiththecollisionenergywas
set at 35%.
2.6. Database Search. For protein identiﬁcation, Mascot
software (Version 2.2.1, Matrix Science, London, UK) was
used to search the human protein sequence database (Swiss-
Prot, Release 52.0 of 22-Feb-08). For proteolytic cleavages,
only tryptic cleavage was allowed, and the number of
maximalinternal(missed)cleavagesiteswassetto2.Variable
modiﬁcations of cysteine with carboxyamidomethylation,
methionine with oxidation, and asparagine/glutamine with
deamidation were allowed. The mass tolerances of the pre-
cursorpeptideionandfragmentionweresetto1Da.Positive
protein identiﬁcations were deﬁned if the Mowse scores of
greater than 50 were considered signiﬁcant (P<0.05).
Proteins were initially annotated by similar searches using
UniProtKB/Swiss-Prot databases (Last modiﬁed September
22, 2009) [19–21].
3. Results andDiscussion
Cell secretome (cell-conditional medium) studies can make
major contributions in understand biomarker discovery
and cell pathophysiological mechanisms. It is composed of
proteins that are found in the extracellular growth medium.
The cell secretome consists of proteins that are secreted, shed
from the cell surface and intracellular proteins released into
the supernatant due to cell lysis, apoptosis, and necrosis [22,
23]. The secretome which consists of proteins or peptides
secreted from cells into the extracellular medium represents
the major class of molecules involved in the intercellular
communication in multicellular organisms. It constitutes
an important class of proteins that control and regulate
a multitude of biological and physiological processes and
indicates a clinically relevant source for biomarker and
therapeutic target discoveries [24].
Thus, secreted proteins constitute an important category
of active molecules that play crucial roles in a number of
physiological and pathological processes and may reﬂect a
broad variety of pathological conditions and thus represent
a rich source of biomarkers. Proteomic characterization of
proteins for identiﬁcation of speciﬁc biomarkers provides a
powerful tool to gain deep insights into disease mechanisms
in which proteins play major roles. In this study, we have
used gel electrophoresis associated with mass spectrometry
for identiﬁcation of the proteome and secretome of HNPE
cell conditioned SF-medium samples.
3.1. RGC-5 Cell Diﬀerentiation. The diﬀerentiation system
consisted of RGC-5 cells on coverslips inside 6-well plates,
which were exposed to the conditioned medium from HNPE
cells. RGC-5 cells proliferated rapidly with a doubling time
of less than a day. Decreasing the percentage of serum in the
medium may slow down proliferation. The control RGC-5
cells were heterogeneous in shape. Morphological changes
of RGC-5 cells were induced by HNPE cell conditioned
SF-medium (Figure 1) and caused the shrinkage of the
cell body with elongated neurite outgrowth (Figure 1(b)),
which allows comparison with undiﬀerentiated RGC-5 cells
(Figure 1(a)). The overall morphology of RGC-5 cells after
thetreatmentwassimilartothoseseeninprimaryculturesof
rat retinal ganglion cells [25]. Moreover, the morphology of
RGC-5 cells diﬀerentiated by our method was similar to the
ones induced by a broad-spectrum protein kinase inhibitor
staurosporine [26]. Nevertheless, Frassetto and coworkers
did not conclude this to be the possible diﬀerentiation
mechanism. This secretome map is a preliminary study to
unveil the mechanism since the diﬀerentiation is probably
the consequence of the action of several proteins and/or
enzymes. It was also noted that the diﬀerentiation treatment
led to decreased culture density compared with the control
cells. This ﬁnding is consistent with the study from Wood
et al. [27]. For subsequent studies, the conditioned medium
from conﬂuent ﬂasks containing HNPE cells was used and
found to be equally eﬀective in promoting diﬀerentiation of
RGC-5 cells.
Thy-1 expression in undiﬀerentiated RGC-5 cells was
used as a marker to identify retinal ganglion cells [28].
After treatment with HNPE cell conditioned SF-medium,
RGC-5 cells have an enhanced Thy-1 expression, compared
to the undiﬀerentiated cells (Figure 2). In the retina, the4 Journal of Biomedicine and Biotechnology
(a) (b)
Figure 1: Morphological changes in RGC-5 cells after treatment with HNPE conditioned SF-medium (40x) (a) before, and (b) after.
The RGC-5 cells treated with HNPE conditioned SF-medium induced morphological changes, including longer axons and more neurite






























Figure 2: Immunocytochemical analysis of Thy-1 and Brn-3b expression in RGC-5 cells diﬀerentiated by treatment with HNPE cell
conditioned SF-medium. Staining with antibodies to the cell surface glycoprotein, Thy-1, have been commonly used as a marker to identify
retinal ganglion cells. After cultivation with HNPE conditioned medium, RGC-5 cells have an enhanced Thy-1 expression, compared to
the undiﬀerentiated cells. RGC-5 cells without cultivation with HNPE conditioned medium express Brn-3b in a diﬀerent pattern compared
with treated RGC-5 cells. Speciﬁcally, Brn-3b has a nuclear localization in RGC-5 cells without cultivation with HNPE conditioned medium;
however, upon treatment, RGC-5 cells express Brn-3b in a more punctate cytosolic manner.
class IV POU domain transcription factor, Brn-3b, was
expressed almost exclusively in subpopulations of ganglion
cells and used to identify RGCs [29]. Brn-3b was regarded
as a marker for diﬀerentiation of RGCs, since Brn-3 factors
were not necessary for the initial speciﬁcation of sensory
neurons, but were essential for their normal diﬀerentiation
and survival [30]. Speciﬁcally, Brn-3b was localized in the
nuclearinRGC-5cells;however,upontreatmentwithHNPE
cell conditioned SF-medium, RGC-5 cells express Brn-3b in
a more punctate cytosolic manner (Figure 2).
3.2. Proteome Analysis. The SDS-PAGE followed by sil-
ver staining resolved the protein bands from HNPE cell
conditioned SF-medium. Figure 3 shows the silver-stained
1D SDS-PAGE of secreted proteins from HNPE cells. Five









































Figure 3: 1D SDS-PAGE image of HNPE conditioned SF-medium
(5μg/well, silver stained, left-hand side: molecular weight marker,
kDa). The gel bands on the middle lane with serial numbers were
analyzed by nano-HPLC-ESI-MS/MS. In the 30 bands, 132 proteins
were identiﬁed. The gel bands on the right-hand side were the cell
lysised proteins.
visualization, and more than 30 protein bands were detected
in the HNPE conditioned SF-medium using the image
analysis software. To identify the proteins, the position of
the 1D SDS-PAGE lane was excised from the gel, washed
to remove the stain, and subjected to tryptic digestion.
The resulting peptides were characterized by nano-HPLC-
MS/MS for protein identiﬁcation. When a protein was iden-
tiﬁed by three or more unique peptides possessing MASCOT
scores, no visual assessment of spectra was conducted and
the protein was considered present in the sample.
In this study, all MS/MS spectra were manually con-
ﬁrmed (even if the above criteria were passed) by the
visual assessment for their overall quality. In addition, the
criteria for manual validation reported by Jaﬀe et al., which
requires a readily observable series of at least four y-ions,
was used [31]. Thus, the criteria should be enough for the
validation of the identiﬁed proteins. By using this strategy,
132 unique proteins with at least three unique peptide
sequences matched were identiﬁed, and a summary of the
protein identiﬁcations achieved is listed in Table 1.
In this study, 47 proteins (35.6%) were known to be
present in cytoplasm. Twenty-two proteins (16.7%) were
knowntobesecretedintotheextracellularspace.Twenty-ﬁve
proteins (18.9%) were known to be nuclear proteins. Eleven
proteins (8.3%) were known to be membrane proteins.
Ten proteins (7.6%) were known to be cytosol proteins.
A few mitochondrial, endoplasmic reticulum, intracellular,
cytoskeleton, and golgi apparatus proteins were also identi-
ﬁed. A considerable portion of the identiﬁed proteins (6%,
8 proteins) has not been reported for their synthesized
locations. Some proteins weredescribed as found in diﬀerent
subcellular locations, which explains the total sum being
substantially larger than 100%.
Some identiﬁed proteins in the distribution of cellular
location were not secreted proteins, but they were still
present in the secreted medium. To clarify the puzzle, a cell
viability test was applied. The survival rate of HNPE cells
was determined by the dimethylthiazol-diphenyltetrazolium
bromide (MTT) assay, which was about 97%. Thus, those
identiﬁed proteins were not corresponding to released
proteins from dead cells. Also, according the protein proﬁles
in Figure 3, the protein patterns obtained from secreted
medium and cell lysate were very diﬀerent. As a result, these
proteins identiﬁed in this study can be considered as secreted
proteins, which may have been synthesized inside the cells
and transferred out.
Based on the functional categories in the Swiss-Prot
and TrEMBL protein database, the identiﬁed proteins were
classiﬁed into several groups. The Swiss-Prot identiﬁers
could be employed for linkages of proteins to deﬁned vocab-
ulary of terms describing the cellular components, biological
processes, and molecular functions of known gene ontology
(GO). Gene Ontology Consortium provides annotations
of each protein and its structure, which allowed us to
organize selected proteins into biologically relevant groups.
These groupings can be utilized as the basis for identifying
biological information showing correlated protein changes
[20, 32]. Such protein functions were listed in Table 2.
In this study, some of the proteins secreted by HNPE
cells, which were conﬁrmed by the Western blotting method,
may be candidate factors responsible for promoting diﬀer-
entiation of RGC-5 cells including thrombospondin-1, 2,
3 precursor (1-2, 1-3, 1-13), galectin-3-binding protein (1-
5∼1-7), neurogenic locus notch homolog protein 3 (Notch-
3,1-11),follistatin-relatedprotein1precursor(1-11),sPARC
precursor (1-14), peroxiredoxin-1 (1-21, 1-22), coﬁlin 1 (1-
24, 1-27), proﬁlin 1 (1-27, 1-28), galectin-1 (1-28), and
myotrophin (1-30). Cell diﬀerentiation is directed by a
variety of intra- and extracellular events including signals
generatedbyextracellularmatrix(ECM)components,which
mediate adhesive cell-to-cell interactions and trigger a cas-
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roles for ECM proteins in cell growth and diﬀerentiation can
be indicated by their abilities to modulate a variety of growth
factors [33].
Thrombospondin (TSP, MW∼420kDa), which belongs
to a multigene family of modular modular glycoproteins,
is composed of three identical subunits within a disulﬁde
linkage. TSP is synthesized by several matrix-forming cells
and is incorporated into their extracellular matrix. In several
celltypes,thisproteinsupportscellgrowthandproliferation.
As a component of ECM, TSP is involved in the regulation of
mediate platelet aggregation, inﬂammation, and angiogene-
sisaswellasadhesion,migration,growth,anddiﬀerentiation
o fan u m b e ro fn o r m a la n dt r a n s f o r m e dc e l l s[ 34, 35]. The
expression of the TSP has been also investigated during
the process of diﬀerentiation of embryonal carcinoma cells,
granulose cells and HL-60 cells in vitro [36–39]. Although
the TSP is prevalent in diﬀerentiated cells, the induced TSP
syntheses during the diﬀerentiation may function diﬀerently
during neurogenesis.
In the eye, TSP-1 is localized in the epiretinal mem-
brane and between the retinal pigment epithelial layer and
Bruch’s membrane, which is a cell-attachment factor with
cell-speciﬁc aﬃnity. TSP-1 production by retinal pigment
epithelial cells is aﬀected by the state of proliferation and
cell density. With its anti-angiogenic activity, TSP-1 may
play several biologic roles on Bruch’s membrane [35]. In
another report, the authors evaluated the bone marrow
stromal cells (BMSCs) secretion of TSP-1, which is a putative
mechanistic agent acting on RGCs for survival and growth
[40]. The BMSC-derived TSP-1 is identiﬁed as a speciﬁc
mediator of reparative processes in neurons, which functions
included enhanced RGC neurite formation, cell survival, and
expression of synaptophysin. It suggested that the TSP-1
signaling pathway might be an important role in neural-like
diﬀerentiationinBMSCsandoutgrowthinRGCs[40].These
observations suggest that the synthesis of TSP contributes to
thediﬀerentiationoptions/alternativesofRGC-5cellstoward
a neural fate, reminiscent of their neural crest origin.
TSP-2 and SPARC (secreted protein, acidic and rich
in cysteine) are classiﬁed as matricellular proteins. TSP-2
appears to play a role in reducing proliferation, while SPARC
may have a positive role in progenitor cell expansion. TSP-
2 and SPARC have been shown to positively inﬂuence
osteoblast diﬀerentiation, with the ability to limit adipoge-
nesis [41, 42].
TSP-3 is structurally similar to cartilage oligomeric
matrix protein (COMP/TSP-5), and was a recently described
member with the calcium binding Type 3 repeats. Like
Type 1 and 2 repeats, TSP-3 is absence of the complement
and contains four epidermal growth factor receptors with a
distinctNterminusthathasnosigniﬁcanthomologytoother
TSPs. TSP-3 is also an oligomeric heparin binding protein
present in both the cell layer and medium [43].
Galectin-3-binding protein (G3BP), also known as Mac-
2 binding protein, is a secreted glycoprotein with a molecular
mass of ∼90kDa present in the extracellular matrix of
cells. Gelectins and their binding proteins have primarily
been described in cell-cell and cell-matrix interactions
and play roles in autoimmunity, inﬂammation and tumor
progression or metastasis [44]. G3BP promotes integrin-
mediated cell adhesion and functions in cancer progression
of human tumor cells. It also binds to multiple proteins in
the extracellular matrix including collagen, ﬁbronectin, and
nidogen,andtomoleculesmediatingcell-cellandcell-matrix
adhesions that are critical during tumor cell invasion and
migration [45–48].
Notch-3 was the third discovered human homologue
of the Drosophila melanogaster type I membrane protein
notch. In Drosophila, the interaction of notch with its cell-
bound ligands (delta and serrate) establishes an intercellular
signaling pathway that plays a key role in neural develop-
ment. Members of the Notch gene family were thought to be
involved as receptors for membrane-bound ligands Jagged1,
J a g g e d 2 ,a n dD e l t a 1i nt h er e g u l a t i o no fc e l lf a t ei nav a r i e t y
of neurogenesis of embryos, particularly in the developing
central nervous system (CNS) from the homogenous cell
population of the neural tube [49, 50]. The Notch-3 activa-
tion induces theincreaseoftheprogenitor cellnumber in the
CNS and aﬀected CNS development. The Notch-3 mutation
may lead to cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL).
CADASIL leads to stroke and dementia and is the main
feature of recurrent subcortical ischemic events and vascular
dementia. Such mutations aﬀect highly-conserved cysteine
residues in epidermal growth factor- (EGF-) like repeat
domain in the extracellular part of the receptor [51, 52].
Follistatin-related protein (FSRP) is a recently discovered
glycoprotein that is highly homologous in both primary
sequence and exon/intron domain structure to the activin-
binding protein, follistatin (FS). FS is a secreted monomeric
glycoprotein and a member of a large group of proteins con-
taining a highly conserved module of cysteine-rich sequence
termed the follistatin domain. It was ﬁrst isolated from ovar-
ian follicular ﬂuid on the basis of its ability to suppress FSH
secretion by pituitary cells in vitro [53]. This follistatin gene
family includes follistatin, follistatin-related gene (FLRG)
protein, follistatin-related protein (FSRP), agrin, secreted
protein acidic, and it is rich in cysteine (SPARC), and Mac25
[54]. A follistatin-like sequence containing 10 conserved
cysteine residues may modulate the action of some growth
factors on cell proliferation and diﬀerentiation. It was also
thought to be an autoantigen associated with rheumatoid
arthritis [55].
SPARC, also known as osteonectin, 43K protein, or
BM-40, is a 32.7kDa calcium- and copper-binding gly-
coprotein, which is a product of natural synthesis from
osteoblasts, endothelial cells, and megakaryocytes. It func-
tions as a counteradhesive protein, as a modulator of
growth factor activity, and as a cell-cycle inhibitor [56].
SPARC belongs to matrix-associated factors that mediate
cell-matrix interactions. Other members of this group
include TSP-1 and -2, osteopontin (OPN), tenascins, and
the SPARC-related proteins. Expressed during many stages
of development in a variety of organisms, the expression
of this matricellular protein, SPARC, is restricted in adult
vertebrates primarily to tissues that undergo consistent
turnover or to sites of injuries and diseases [56]. Vertebrate
SPARC binds to a number of diﬀerent ECM components24 Journal of Biomedicine and Biotechnology
including albumin, thrombospondin 1, PDGF, vitronectin,
entactin/nidogen, ﬁbrillar collagens (types I, II, III, and
V), and collagen type IV, the prevalent collagen in base-
ment membranes [57]. The ability of SPARC to bind to
several resident ECM proteins aﬀects the expression of
matrix metalloproteinases and adjusts eﬀects of growth
factors; as a counteradhesive factor of cell shape change,
this supports SPARC to regulate cell interactions during
their development [57]. SPARC appears to regulate cell
growth through interactions with the extracellular matrix
and cytokines. It is also a matricellular protein that
modulates cell adhesion and proliferation and is thought
to function in tissue remodeling and angiogenesis [58,
59].
Peroxiredoxin (PRDX) is a recently identiﬁed family
of antioxidative proteins that includes six isoforms in
mammals. They share a common reactive Cys residue in the
N-terminal region and are capable of serving as a peroxidase,
involving thioredoxin and/or glutathione as the electron
donor. PRDX 1–4 have an additional reactive Cys residue in
the conserved C-terminal region and show >70% amino acid
sequence homology. In this capacity, they may be involved in
the protection of cells from oxidative stress. Peroxiredoxin1
(PRDX1) is ubiquitously expressed and functions as an
antioxidant enzyme, which reduces hydrogen peroxide and
alkyl hydroperoxide and is involved in cellular prolifera-
tion, diﬀerentiation, apoptosis, and innate immunity [60].
PRDX1 may participate in the signal cascades of growth fac-
tors and tumor necrosis factor-α by regulating the intracellu-
lar concentrations of hydrogen peroxide [61–63]. A previous
studyalsoappliedaproteomicapproachtostudyPRDX1,-2,
and -3 expressions in Alzheimer’s diseases and Down’s syn-
drome,andfoundasigniﬁcantincreaseinPRDX1expression
associated with the neurodegenerative diseases [64].
The human coﬁlin protein has a molecular weight
of approximately 21kDa. It is a member of the actin
depolymerization factor (ADF)/coﬁlin family. Coﬁlin is an
essential cellular protein that can bind the barbed end of
actin and is required for cell viability [65]. In cells, coﬁlin
acts in harmony with other regulatory proteins to mediate
the response of the actin cytoskeleton to extracellular signals.
In vertebrates, coﬁlin is regulated by pH, phosphorylation
and phosphoinositides. It is involved in the translocation of
the actin-coﬁlin complex from cytoplasm to nucleus. Coﬁlin
plays an essential role in actin ﬁlament dynamics by enhanc-
ing depolymerization and severance of actin ﬁlaments [66].
These activities of coﬁlin can be abolished by phosphoryla-
tion at Ser-3; therefore, phosphorylation/dephosphorylation
of coﬁlin at Ser-3 is regarded as one of the important mech-
anisms for regulating coﬁlin activities and actin ﬁlament
dynamics [67]. Sinha et al. reported that the suppression of
coﬁlin might lead to cancer regression [68].
Proﬁlin-1 (PFN1) is a widely and highly expressed 14-
to 17-kDa cytoplasmic and nuclear ligand protein of the
microﬁlament system. It is a ubiquitous actin monomer-
binding protein involved in actin polymerization in response
to extracellular signaling pathways. PFN1 plays a central role
in the regulation of de novo actin assembly by preventing
spontaneous actin polymerisation through the binding of
actin monomers and addition of monomeric actin to
the barbed actin-ﬁlament ends [69] .T h ei m p o r t a n c eo f
proﬁlinsfornormalcellproliferation,diﬀerentiation,cellular
survival, motility, adhesion, migration, and cytoskeleton
remodelling has been veriﬁed [69–72]. PFN1 may be a
tumor suppressor because its expression was reduced in
several types of invasive cancers and it was able to sup-
press tumorigenicity when overexpressed [73]. In addition,
the immunohistochemistry analysis also showed low levels
of PFN1 in several human breast cancers. Other than
being a tumor suppressor, PFN1 was reported as a nec-
essary element for diﬀerentiation of human epithelial cells
[74].
Galectins are a family of structurally related carbohy-
drate-binding proteins and widely distributed in nema-
todes, insects, and porifer, as well as vertebrates and
fungi [75]. They are deﬁned by their aﬃnity for poly-
N-acetyllactosamine-enrichedglycoconjugatesandsequence
similarities in the carbohydrate recognition domain. The
galectins are a family of β-galactoside-binding proteins im-
plicated in modulating cell-cell and cell-matrix interactions,
which would be required for protein secretion through the
classical secretory pathways found in the extracellular space
[76].
Galectin-1 is expressed during human embryogenesis,
and many adult cell types express and secrete galectin-1
into the extracellular matrix [76]. Galectin-1 contributes to
diﬀerent events associated with cancer biology, including
tumour transformation, proliferation, diﬀerentiation, cell
cycle regulation, growth arrest, apoptosis, cell adhesion,
migration, inﬂammation, and inhibition of full cell acti-
vation [77]. A previous study has shown that galectin-1
induced sustained exposure of phosphatidylserine on the cell
surface in a carbohydrate-dependent fashion, but phosphati-
dylserine exposure is not associated with cell death by
apoptosis and does not aﬀect cell viability. There is evidence
that galectin-1 contributes to tumour evasion of immune
responses [78].
A positive correlation has recently been shown between
galectin-3 expression and the degree of malignant transfor-
mation in certain types of cell lines, and the amount of
galectin-3expressionisexpectedtopossiblyserveasanindex
of degree for neoplastic transformation, tumor cell survival,
angiogenesis, tumor metastasis, and tumor malignancy [79,
80]. Recent studies have revealed that intracellular galectin-
3 exhibits the activity to suppress drug-induced apoptosis
and anoikis that contribute to cell survival. Resistance to
apoptosis is essential for cancer cell survival and plays a role
in tumor progression [81].
Moreover, both galectin-1 and galectin-3 expressions are
necessary for the initiation of the transformed phenotype
of tumors. Inhibition of galectin-1 expression can suppress
the transformed phenotype of human glioma cells [82]. In
addition, following the inhibition of galectin-3 expression,
breast carcinoma cells and thyroid papillary carcinoma cells
lose their transformed characteristic phenotypes in cell
culture [83, 84].
Myotrophin, a 12kDa protein consists of 117 amino
acids, has a potential role in cerebellar morphogenesis andJournal of Biomedicine and Biotechnology 25
may be involved in diﬀerentiation of cerebellar neurons,
particularly of granule cells, and associated with cardiac
hypertrophy. It appears to be a primary modulator for
myocardial cell growth and diﬀerentiation [85]. Myotrophin
accelerates myocyte growth by stimulating protein synthesis
and may be correlated with cardiac hypertrophy in the
pathogenesis,whereitisinvolvedintheconversionofNF-κB
p50-p65 heterodimers to p50-p50 and p65-p65 homodimers
as well as in the normal development of cardiac myocytes
[86].Apreviousstudyalsoindicatedthatmyotrophinmaybe
involved in the upregulation of myoﬁbrillar protein and the
activation of cardiac gene transcription during the growth
andhypertrophyofmyocardium;thus,theinductionofearly
response of gene expression may be linked to this response
[87].
The 132 proteins identiﬁed in this study may be involved
in some biologic processes that are associated with cell
diﬀerentiation, proliferation, and adhesion. We have tested
some proteins incorporated into the medium; however, none
of those proteins can solely induce cell diﬀerentiation. The
results form a database with a diversity and relative abun-
dance of various proteins found in the HNPE cell-secreted
proteins. The database provides not only information on the
nature of protein contents in HNPE cells but also potential
proteins to be examined in further investigations.
4. Conclusions
In this study, we established the ﬁrst secretome database
for HNPE cells. The experimental results obtained by SDS-
PAGE and nano-high performance liquid chromatography
electrospray ionization tandem mass spectrometry (nano-
HPLC-ESI-MS/MS) system revealed the identiﬁcation of
132 unique proteins from HNPE cell secretome. Among
these 132 proteins identiﬁed with higher conﬁdence lev-
els, some proteins have been reported involving in cell
diﬀerentiation, such as thrombospondin-1, 2, 3 precursor,
galectin-3-binding protein, neurogenic locus notch homolog
protein 3, follistatin-related protein 1 precursor, sPARC
precursor, peroxiredoxin-1, coﬁlin 1, proﬁlin 1, galectin-1,
andmyotrophin.However,noneofthoseproteinscaninduce
cell diﬀerentiation solely. This list serves as a starting point
for buildingup a comprehensive database of the proteome
of this cell-line. The database can include diverse repertoires
of proteins expressed by HNPE cells. All of this data will
enhance our understanding of the molecular mechanisms
involved in maintaining the diﬀerentiated states of HNPE
cells and directing their diﬀerentiation and, in turn, will
bring us closer to fulﬁll the vast clinical potentials of the
cells.
In conclusion, we have demonstrated that RGC-5 cells
upon coculturing with HNPE cell conditioned SF-medium
developed a diﬀerentiated morphology and continued to
express the necessary RGC markers. The diﬀerentiated RGC-
5 cells would therefore be useful to study apoptotic pathways
of retinal ganglion cell death. The ﬁndings from this study
may have signiﬁcant impacts on HNPE cell biology and cell
engineering.
Acknowledgments
This paper was supported by research Grants Q097004





[ 1 ]V .R .R a o ,R .R .K r i s h n a m o o r t h y ,a n dT .Y o r i o ,“ E n d o t h e l i n -
1 mediated regulation of extracellular matrix collagens in cells
ofhumanlaminacribrosa,”ExperimentalEyeResearch,vol.86,
no. 6, pp. 886–894, 2008.
[2] M. Hern´ andez, J. H. Urcola, and E. Vecino, “Retinal ganglion
cell neuroprotection in a rat model of glaucoma following bri-
monidine,latanoprostorcombinedtreatments,”Experimental
Eye Research, vol. 86, no. 5, pp. 798–806, 2008.
[3] H. Quigley and A. T. Broman, “The number of people with
glaucoma worldwide in 2010 and 2020,” British Journal of
Ophthalmology, vol. 90, no. 3, pp. 262–267, 2006.
[4] H. A. Quigley, “Glaucoma: macrocosm to microcosm the
Friedenwald lecture,” Investigative Ophthalmology and Visual
Science, vol. 46, no. 8, pp. 2663–2670, 2005.
[5] J. E. Morgan, H. Uchida, and J. Caprioli, “Retinal ganglion
cell death in experimental glaucoma,” British Journal of
Ophthalmology, vol. 84, no. 3, pp. 303–310, 2000.
[6] G. R. Howell, R. T. Libby, T. C. Jakobs et al., “Axons of retinal
ganglion cells are insulted in the optic nerve early in DBA/2J
glaucoma,” Journal of Cell Biology, vol. 179, no. 7, pp. 1523–
1537, 2007.
[7] N. A. Castle, “Aquaporins as targets for drug discovery,” Drug
Discovery Today, vol. 10, no. 7, pp. 485–493, 2005.
[ 8 ]R .W .R o d i e c k ,The First Steps in Seeing, Sinauer Associates,
Sunderland, Mass, USA, 1998.
[9] B. Schwartz, J. C. Rieser, and S. L. Fishbein, “Fluorescein
angiographic defects of the optic disc in glaucoma,” Archives
of Ophthalmology, vol. 95, no. 11, pp. 1961–1974, 1977.
[10] C. J. Barnstable and U. C. Drager, “Thy-1 antigen: a ganglion
cell speciﬁc marker in rodent retina,” Neuroscience, vol. 11, no.
4, pp. 847–855, 1984.
[11] Z. Q. Xiang, B. B. Knowles, J. W. McCarrick, and H. C. J.
Ertl, “Immune eﬀector mechanisms required for protection to
rabies virus,” Virology, vol. 214, no. 2, pp. 398–404, 1995.
[12] Y.Otori,S.Kusaka,A.Kawasaki,H.Morimura,A.Miki,andY.
Tano, “Protective eﬀect of nilvadipine against glutamate neu-
rotoxicity in puriﬁed retinal ganglion cells,” Brain Research,
vol. 961, no. 2, pp. 213–219, 2003.
[13] M. Coca-Prados, J. Escribano, and J. Ortego, “Diﬀerential
gene expression in the human ciliary epithelium,” Progress in
Retinal and Eye Research, vol. 18, no. 3, pp. 403–429, 1999.
[14] J. Escribano, J. Ortego, and M. Coca-Prados, “Isolation
and characterization of cell-speciﬁc cDNA clones from a
subtractive library of the ocular ciliary body of a single
normal human donor: transcription and synthesis of plasma
proteins,” Journal of Biochemistry, vol. 118, no. 5, pp. 921–931,
1995.
[15] J. Ortego and M. Coca-Prados, “Molecular characterization
anddiﬀerential geneinductionof theneuroendocrine-speciﬁc
genes neurotensin, neurotensin receptor, PC1, PC2, and
7B2 in the human ocular ciliary epithelium,” Journal of
Neurochemistry, vol. 69, no. 5, pp. 1829–1839, 1997.26 Journal of Biomedicine and Biotechnology
[16] N. J. van Bergen, J. P. Wood, G. Chidlow et al., “Recharacter-
ization of the RGC-5 retinal ganglion cell line,” Investigative
Ophthalmology and Visual Science, vol. 50, no. 9, pp. 4267–
4272, 2009.
[ 1 7 ]Y .C .T y a n ,H .Y .W u ,W .C .S u ,P .W .C h e n ,a n dP .C .L i a o ,
“Proteomic analysis of human pleural eﬀusion,” Proteomics,
vol. 5, no. 4, pp. 1062–1074, 2005.
[18] Y. C. Tyan, H. Y. Wu, W. W. Lai, W. C. Su, and P. C.
Liao, “Proteomic proﬁling of human pleural eﬀusion using
two-dimensional nano liquid chromatography tandem mass
spectrometry,” Journal of Proteome Research,v o l .4 ,n o .4 ,p p .
1274–1286, 2005.
[19] A. Pandey, A. V. Podtelejnikov, B. Blagoev, X. R. Bustelo,
M. Mann, and H. F. Lodish, “Analysis of receptor signaling
pathways by mass spectrometry: identiﬁcation of vav-2 as a
substrate of the epidermal and platelet-derived growth factor
receptors,” Proceedings of the National Academy of Sciences of
the United States of America, vol. 97, no. 1, pp. 179–184, 2000.
[20] C. O’Donovan, M. J. Martin, A. Gattiker, E. Gasteiger, A.
Bairoch, and R. Apweiler, “High-quality protein knowledge
resource: SWISS-PROT and TrEMBL,” Brieﬁngs in Bioinfor-
matics, vol. 3, no. 3, pp. 275–284, 2002.
[21] E. Gasteiger, A. Gattiker, C. Hoogland, I. Ivanyi, R. D. Appel,
and A. Bairoch, “ExPASy: the proteomics server for in-depth
protein knowledge and analysis,” Nucleic Acids Research, vol.
31, no. 13, pp. 3784–3788, 2003.
[22] S.R.Piersma,U.Fiedler,S.Span etal.,“Workﬂowcomparison
for label-free, quantitative secretome proteomics for cancer
biomarker discovery: method evaluation, diﬀerential analysis,
and veriﬁcation in serum,” Journal of Proteome Research, vol.
9, no. 4, pp. 1913–1922, 2010.
[23] M. Makridakis and A. Vlahou, “Secretome proteomics for
discovery of cancer biomarkers,” Journal of Proteomics, vol. 73,
no. 12, pp. 2291–2305, 2010.
[24] Y. Hathout, “Approaches to the study of the cell secretome,”
Expert Review of Proteomics, vol. 4, no. 2, pp. 239–248, 2007.
[25] I. Surgucheva, A. D. Weisman, J. L. Goldberg, A. Shnyra, and
A. Surguchov, “γ-synuclein as a marker of retinal ganglion
cells,” Molecular Vision, vol. 14, pp. 1540–1548, 2008.
[26] L. J. Frassetto, C. R. Schlieve, C. J. Lieven et al., “Kinase-
dependent diﬀerentiation of a retinal ganglion cell precursor,”
Investigative Ophthalmology and Visual Science, vol. 47, no. 1,
pp. 427–438, 2006.
[ 2 7 ]J .P .W o o d ,G .C h i d l o w ,T .T r a n ,J .G .C r o w s t o n ,a n dR .J .
Casson, “A comparison of diﬀerentiation protocols for RGC-
5c e l l s , ”Investigative Ophthalmology & Visual Science, vol. 51,
no. 7, pp. 3774–3783, 2010.
[28] R. R. Krishnamoorthy, P. Agarwal, G. Prasanna et al., “Char-
acterization of a transformed rat retinal ganglion cell line,”
Molecular Brain Research, vol. 86, no. 1-2, pp. 1–12, 2001.
[29] L. Gan, S. W. Wang, Z. Huang, and W. H. Klein, “POU
domain factor Brn-3b is essential for retinal ganglion cell
diﬀerentiation and survival but not for initial cell fate
speciﬁcation,” Developmental Biology, vol. 210, no. 2, pp. 469–
480, 1999.
[30] X.MuandW.H.Klein,“Ageneregulatoryhierarchyforretinal
ganglion cell speciﬁcation and diﬀerentiation,” Seminars in
Cell and Developmental Biology, vol. 15, no. 1, pp. 115–123,
2004.
[31] J. D. Jaﬀe, H. C. Berg, and G. M. Church, “Proteogenomic
mapping as a complementary method to perform genome
annotation,” Proteomics, vol. 4, no. 1, pp. 59–77, 2004.
[ 3 2 ]Y .G u o ,S .F .M a ,D .G r i g o r y e v ,J .V a nE y k ,a n dJ .G .N .
Garcia, “1-DE MS and 2-D LC-MS analysis of the mouse
bronchoalveolar lavage proteome,” Proteomics, vol. 5, no. 17,
pp. 4608–4624, 2005.
[33] N. M. Kumar, S. L. Sigurdson, D. Sheppard, and J. S. Lwebuga-
Mukasa, “Diﬀerential modulation of integrin receptors and
extracellular matrix laminin by transforming growth factor-
β1 in rat alveolar epithelial cells,” Experimental Cell Research,
vol. 221, no. 2, pp. 385–394, 1995.
[34] V. Alessandra, D. M. Lucia, G. Giuseppe et al.,
“Thrombospondin-1 is a mediator of the neurotypic
diﬀerentiation induced by EGF in thymic epithelial cells,”
Experimental Cell Research, vol. 248, no. 1, pp. 79–86, 1999.
[35] H.Miyajima-Uchida,H.Hayashi,R.Beppuetal.,“Production
and accumulation of thrombospondin-1 in human retinal
pigment epithelial cells,” Investigative Ophthalmology and
Visual Science, vol. 41, no. 2, pp. 561–567, 2000.
[36] D. J. Liska, R. Hawkins, K. Wikstrom, and P. Bornstein, “Mod-
ulation of thrombospondin expression during diﬀerentiation
of embryonal carcinoma cells,” Journal of Cellular Physiology,
vol. 158, no. 3, pp. 495–505, 1994.
[37] S. J. Suchard, P. J. Mansﬁeld, and V. M. Dixit, “Modulation
of thrombospondin receptor expression during HL-60 cell
diﬀerentiation,” Journal of Immunology, vol. 152, no. 2, pp.
877–888, 1994.
[38] M. Dreyfus, R. Dardik, B. S. Suh, A. Amsterdam, and J.
Lahav, “Diﬀerentiation-controlled synthesis and binding of
thrombospondin to granulosa cells,” Endocrinology, vol. 130,
no. 5, pp. 2565–2570, 1992.
[39] K. S. O’Shea and V. M. Dixit, “Unique distribution of
the extracellular matrix component thrombospondin in the
developing mouse embryo,” J o u r n a lo fC e l lB i o l o g y , vol. 107,
no. 6, pp. 2737–2748, 1988.
[40] K. Yu, J. Ge, J. B. Summers et al., “TSP-1 secreted by
one marrow stroma cells contributes to retinal ganglion cell
neurite outgrowth and survival,” PLoS One, vol. 3, no. 6,
Article ID e2470, pp. 1–11, 2008.
[41] A. E. Canﬁeld, A. B. Sutton, J. A. Hoyland, and A. M.
Schor, “Association of thrombospondin-1 with osteogenic
diﬀerentiation of retinal pericytes in vitro,” Journal of Cell
Science, vol. 109, no. 2, pp. 343–353, 1996.
[42] A. M. Delany and K. D. Hankenson, “Thrombospondin-
2 and SPARC/osteonectin are critical regulators of bone
remodeling,”JournalofCellCommunicationandSignaling,vol.
3, no. 3-4, pp. 227–238, 2009.
[43] A. N. Qabar, Z. Lin, F. W. Wolf, K. S. O’Shea, J. Lawler, and V.
M. Dixit, “Thrombospondin 3 is a developmentally regulated
heparin binding protein,” Journal of Biological Chemistry, vol.
269, no. 2, pp. 1262–1269, 1994.
[44] M. Blostein, J. Cuerquis, and J. Galipeau, “Galectin 3-binding
protein is a potential contaminant of recombinantly produced
factor IX,” Haemophilia, vol. 13, no. 6, pp. 701–706, 2007.
[45] T. Plavina, E. Wakshull, W. S. Hancock, and M. Hincapie,
“Combination of abundant protein depletion and multi-
lectin aﬃnity chromatography (M-LAC) for plasma protein
biomarker discovery,” Journal of Proteome Research, vol. 6, no.
2, pp. 662–671, 2007.
[46] G. Calabrese, I. Sures, F. Pompetti, G. Natoli, G. Palka, and S.
Iacobelli, “The gene (LGALS3BP) encoding the serum protein
90K, associated with cancer and infection by the human
immunodeﬁciency virus, maps at 17q25,” Cytogenetics and
Cell Genetics, vol. 69, no. 3-4, pp. 223–225, 1995.
[47] K. Koths, E. Taylor, R. Halenbeck, C. Casipit, and A. Wang,
“Cloning and characterization of a human Mac-2-binding
protein, a new member of the superfamily deﬁned by the
macrophagescavengerreceptorcysteine-richdomain,”JournalJournal of Biomedicine and Biotechnology 27
of Biological Chemistry, vol. 268, no. 19, pp. 14245–14249,
1993.
[48] Y. Fukaya, H. Shimada, L. C. Wang, E. Zandi, and Y. A.
DeClerck, “Identiﬁcation of galectin-3-binding protein as a
factor secreted by tumor cells that stimulates interleukin-6
e x p r e s s i o ni nt h eb o n em a r r o ws t r o m a , ”Journal of Biological
Chemistry, vol. 283, no. 27, pp. 18573–18581, 2008.
[49] S. A. Sullivan, L. K. Barthel, B. L. Largent, and P. A. Raymond,
“A goldﬁsh Notch-3 homologue is expressed in neurogenic
regions of embryonic, adult and regenerating brain and
retina,” Developmental Genetics, vol. 20, no. 3, pp. 208–223,
1997.
[50] Y. Qu, K. Sakamoto, S. Takeda, T. Kayano, M. Takagi, and
K. Katsube, “Diﬀerential expression of notch genes in the
neurogenesis of mouse embryos,” Oral Medicine & Pathology,
vol. 3, pp. 21–28, 1998.
[51] M. Lardelli, R. Williams, T. Mitsiadis, and U. Lendahl,
“Expression of the Notch 3 intracellular domain in mouse
central nervous system progenitor cells is lethal and leads to
disturbed neural tube development,” Mechanisms of Develop-
ment, vol. 59, no. 2, pp. 177–190, 1996.
[52] A. Joutel, C. Corpechot, A. Ducros et al., “Tournier-Lasserve,
Notch3 mutations in CADASIL, a hereditary adult-onset
condition causing stroke and dementia,” Nature, vol. 383, no.
6602, pp. 707–710, 1996.
[53] D. V. Tortoriello, Y. Sidis, D. A. Holtzman, W. E. Holmes,
and A. L. Schneyer, “Human follistatin-related protein: a
structural homologue of follistatin with nuclear localization,”
Endocrinology, vol. 142, no. 8, pp. 3426–3434, 2001.
[54] J. Liu, T. V¨ anttinen, C. Hyd´ en-Granskog, and R. Voutilainen,
“Regulation of follistatin-related gene (FLRG) expression
by protein kinase C and prostaglandin E(2) in cultured
granulosa-luteal cells,” Molecular Human Reproduction, vol. 8,
no. 11, pp. 992–997, 2002.
[55] Y. Ehara, D. Sakurai, N. Tsuchiya et al., “Follistatin-related
protein gene (FRP) is expressed in the synovial tissues of
rheumatoid arthritis, but its polymorphisms are not asso-
ciated with genetic susceptibility,” Clinical and Experimental
Rheumatology, vol. 22, no. 6, pp. 707–712, 2004.
[56] R. A. Brekken and E. H. Sage, “SPARC, a matricellular protein:
at the crossroads of cell-matrix communication,” Matrix
Biology, vol. 19, no. 8, pp. 815–827, 2001.
[ 5 7 ]A .D .B r a d s h a wa n dE .H .S a g e ,“ S P A R C ,am a t r i c e l l u l a r
protein that functions in cellular diﬀerentiation and tissue
response to injury,” Journal of Clinical Investigation, vol. 107,
no. 9, pp. 1049–1054, 2001.
[58] A. D. Bradshaw, J. A. Bassuk, A. Francki, and E. H. Sage,
“Expression and puriﬁcation of recombinant human SPARC
produced by baculovirus,” Molecular Cell Biology Research
Communications, vol. 3, no. 6, pp. 345–351, 2000.
[59] M. J. Alvarez, F. Prada, E. Salvatierra et al., “Secreted protein
acidic and rich in cysteine produced by human melanoma
cells modulates polymorphonuclear leukocyte recruitment
and antitumor cytotoxic capacity,” Cancer Research, vol. 65,
no. 12, pp. 5123–5132, 2005.
[60] J. Nawarak, R. Huang-Liu, S. H. Kao et al., “Proteomics
analysisofA375humanmalignantmelanomacellsinresponse
to arbutin treatment,” Biochimica etBiophysica Acta, vol. 1794,
no. 2, pp. 159–167, 2009.
[61] K. A. Daly, C. Lef´ evre, K. Nicholas, E. Deane, and P.
Williamson, “Characterization and expression of Peroxire-
doxin 1 in the neonatal tammar wallaby (Macropus eugenii),”
Comparative Biochemistry and Physiology—B, vol. 149, no. 1,
pp. 108–119, 2008.
[62] W. Lee, K. S. Choi, J. Riddell et al., “Human peroxiredoxin 1
and2arenotduplicateproteins:theuniquepresenceofCYS83
in Prx1 underscores the structural and functional diﬀerences
between Prx1 and Prx2,” Journal of Biological Chemistry, vol.
282, no. 30, pp. 22011–22022, 2007.
[63] P. Karihtala, A. M¨ antyniemi, S. W. Kang, V. L. Kinnula, and
Y. Soini, “Peroxiredoxins in breast carcinoma,” Clinical Cancer
Research, vol. 9, no. 9, pp. 3418–3424, 2003.
[64] S. H.Kim,M.Fountoulakis, N.Cairns,and G.Lubec, “Protein
levels of human peroxiredoxin subtypes in brains of patients
with Alzheimer’s disease and Down Syndrome,” Journal of
Neural Transmission, Supplement, no. 61, pp. 223–235, 2001.
[65] P. Lappalainen and D. G. Drubin, “Coﬁlin promotes rapid
actin ﬁlament turnover in vivo,” Nature, vol. 388, no. 6637,
pp. 78–82, 1997.
[66] A. McGough, B. Pope, W. Chiu, and A. Weeds, “Coﬁlin
changes the twist of F-actin: implications for actin ﬁlament
dynamics and cellular function,” J o u r n a lo fC e l lB i o l o g y , vol.
138, no. 4, pp. 771–781, 1997.
[67] J. Toshima, J. Y. Toshima, T. Amano, N. Yang, S. Narumiya,
and K. Mizuno, “Coﬁlin phosphorylation by protein kinase
testicular protein kinase 1 and its role in integrin-mediated
actin reorganization and focal adhesion formation,” Molecular
Biology of the Cell, vol. 12, no. 4, pp. 1131–1145, 2001.
[68] P. Sinha, G. Hutter, E. Kottgen, M. Dietel, D. Schadendorf, and
H. Lage, “Increased expression of epidermal fatty acid binding
protein, coﬁlin, and 14-3-3-sigma (stratiﬁn) detected by
two-dimensional gel electrophoresis, mass spectrometry and
microsequencing of drug-resistant human adenocarcinoma of
the pancreas,” Electrophoresis, vol. 20, pp. 2952–2960, 1999.
[69] W. Witke, J. D. Sutherland, A. Sharpe, M. Arai, and D.
J. Kwiatkowski, “Proﬁlin I is essential for cell survival and
cell division in early mouse development,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 98, no. 7, pp. 3832–3836, 2001.
[70] M. Haugwitz, A. A. Noegel, J. Karakesisoglou, and M. Schle-
icher, “Dictyostelium amoebae that lack G-actin-sequestering
proﬁlins show defects in F-actin content, cytokinesis, and
development,” Cell, vol. 79, no. 2, pp. 303–314, 1994.
[71] E. M. Verheyen and L. Cooley, “Proﬁlin mutations disrupt
multiple actin-dependent processes during Drosophila devel-
opment,” Development, vol. 120, no. 4, pp. 717–728, 1994.
[72] D. J. Mazzatti, G. Pawelec, R. Longdin, J. R. Powell, and R.
J. Forsey, “SELDI-TOF-MS ProteinChip array proﬁling of T-
cell clones propagated in long-term culture identiﬁes human
proﬁlin-1 as a potential bio-marker of immunosenescence,”
Proteome Science, vol. 5, article 7, pp. 1–13, 2007.
[73] L. Zou, M. Jaramillo, D. Whaley et al., “Proﬁlin-1 is a
negative regulator of mammary carcinoma aggressiveness,”
British Journal of Cancer, vol. 97, no. 10, pp. 1361–1371, 2007.
[74] N. Wittenmayer, B. Jandrig, M. Rothkegel et al., “Tumor
suppressor activity of proﬁlin requires a functional actin
binding site,” Molecular Biology of the Cell,v o l .1 5 ,n o .4 ,p p .
1600–1608, 2004.
[75] J. Hirabayashi, T. Hashidate, Y. Arata et al., “Oligosaccharide
speciﬁcity of galectins: a search by frontal aﬃnity chromatog-
raphy,” Biochimica et Biophysica Acta, vol. 1572, no. 2-3, pp.
232–254, 2002.
[76] F. A. Van Den Brˆ ule, P. L. Fernandez, C. Buicu et al., “Dif-
ferential expression of galectin-1 and galectin-3 during ﬁrst
trimester human embryogenesis,” Developmental Dynamics,
vol. 209, no. 4, pp. 399–405, 1997.
[77] G. A. Rabinovich, “Galectin-1 as a potential cancer target,”
British Journal of Cancer, vol. 92, no. 7, pp. 1188–1192, 2005.28 Journal of Biomedicine and Biotechnology
[78] K. Stowell, N. Pollock, and E. Langton, “Perinatal diagnosis
of malignant hyperthermia susceptibility,” Anaesthesia and
Intensive Care, vol. 35, no. 3, pp. 454–455, 2007.
[79] H. J. Gabius, “Concepts of tumor lectinology,” Cancer Investi-
gation, vol. 15, no. 5, pp. 454–464, 1997.
[80] H. Legendre, C. Decaestecker, N. Nagy et al., “Prognostic
values of galectin-3 and the macrophage migration inhibitory
factor (MIF) in human colorectal cancers,” Modern Pathology,
vol. 16, no. 5, pp. 491–504, 2003.
[81] S. Nakahara, N. Oka, and A. Raz, “On the role of galectin-3 in
cancer apoptosis,” Apoptosis, vol. 10, no. 2, pp. 267–275, 2005.
[ 8 2 ]K .G o l d r i n g ,G .E .J o n e s ,R .T h i a g a r a j a h ,a n dD .J .W a t t ,“ T h e
eﬀect of galectin-1 on the diﬀerentiation of ﬁbroblasts and
myoblasts in vitro,” Journal of Cell Science, vol. 115, no. 2, pp.
355–366, 2002.
[83] H. P. Hahn, M. Pang, J. He et al., “Galectin-1 induces nuclear
translocation of endonuclease G in caspase- and cytochrome
c-independent T cell death,” Cell Death and Diﬀerentiation,
vol. 11, no. 12, pp. 1277–1286, 2004.
[ 8 4 ]J .E l l e r h o r s t ,T .N g u y e n ,D .N .C o o p e r ,Y .E s t r o v ,D .L o t a n ,
and R. Lotan, “Induction of diﬀerentiation and apoptosis in
the prostate cancer cell line LNCaP by sodium butyrate and
galectin-1,” InternationalJournalofOncology, vol. 14, pp. 225–
232, 1999.
[85] R. J. O’Brien, I. Loke, J. E. Davies, I. B. Squire, and L. L. Ng,
“Myotrophin in human heart failure,” Journal of the American
College of Cardiology, vol. 42, no. 4, pp. 719–725, 2003.
[86] P. Sil, D. Mukherjee, and S. Sen, “Quantiﬁcation of
myotrophin from spontaneously hypertensive and normal rat
hearts,” Circulation Research, vol. 76, no. 6, pp. 1020–1027,
1995.
[87] D. P. Mukherjee, C. F. McTiernan, and S. Sen, “Myotrophin
induces early response genes and enhances cardiac gene
expression,” Hypertension, vol. 21, no. 2, pp. 142–148, 1993.